New U.S. Rule Mandates Breast Density Notifications After Mammograms

The FDA requires mammography centers to inform women of breast density, sparking debate over additional cancer screening needs.

Breast density notifications are now mandatory nationwide, though 39 states already had similar requirements.
Dense breast tissue can obscure cancer detection on mammograms and slightly increases cancer risk.
Experts disagree on the necessity of additional imaging tests like ultrasounds or MRIs for women with dense breasts.
Insurance coverage for supplemental screenings varies, with potential high out-of-pocket costs for patients.
Some health advocates express concern that the notifications might lead to confusion and unnecessary anxiety among women.